TABLE 1.
Demographic and clinical characteristics of patients with Parkinson’s disease and healthy controls.
| Parkinson’s disease (n = 75) | Healthy controls (n = 34) | |
| Gender (F:M) | 10:65 | 8:26 |
| Age (years) | 57.70 ± 7.41 | 56.05 ± 5.27 |
| Age at onset (years) | 51.14 ± 9.08 | – |
| Duration of illness (years) | 5.87 ± 2.74 | – |
| MMSE score | 28.04 ± 1.61 | |
| UPDRS III (OFF) | 34.53 ± 8.25 | |
| Hoehn and Yahr stage | 2.31 ± 0.28 | |
| LEDD | 616.01 ± 277.65 | – |
F, female; M, male; MMSE, Mini-Mental Status Examination; UPDRS, Unified Parkinson’s Disease Rating Scale; LEDD, levodopa equivalent daily dose.